MacroGenics Provides Update on Corporate Progress and Second Quarter 2020 Financial Results

NEXT STORY
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
PREV STORY
Tiziana Life Sciences plc: Early notification of proposed admission to the Official List and cancellation of trading on AIM
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OpGen Releases Preliminary Data Demonstrating its Unyvero HPN Panel for Pneumonia Identifies Life-Threatening Bacterial Co-Infections in COVID-19 Patients in Just Five Hours

author_avatar
NASDAQ Market News

FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolumab (Opdivo®)

author_avatar
NASDAQ Market News

Celsion Corporation Reports Second Quarter 2017 Financial Results and Provides Business Update

LAWRENCEVILLE, N.J., Aug. 15, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), an oncology drug ...

author_avatar
NASDAQ Market News